You are here

  • Home
  • Archive
  • Volume 11, Issue 8
  • Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women

Citation Tools

Article menu
XML
Dermatology
Protocol
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Renz S, Chinnery F, Stuart B, et al
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women
BMJ Open 2021;11:e053876. doi: 10.1136/bmjopen-2021-053876